New magnetic resonance contrast agents as biochemical reporters

Current Opinion in Neurobiology

Volumn 13, Issue 5, 2003, Pages 597-602

  Meade, Thomas J ^a   Taylor, Alisha K ^a   Bull, Steven R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7 TRIS(CARBOXYMETHYL) 1,4,7,10 TETRAAZACYCLODODECANE GADOLINIUM; 4,7,10 TRI(ACETIC ACID) 1 (2 BETA GALACTOPYRANOSYLETHOXY) 1,4,7,10 TETRAAZACYCLODODECANE GADOLINIUM; BETA GALACTOSIDASE; CHEMICAL EXCHANGE SATURATION TRANSFER AGENT; CROSS LINKED IRON DIOXIDE; DEOXYHEMOGLOBIN; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; ION; LANTHANIDE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG;

BIOLOGY; CELL METABOLISM; COMPLEX FORMATION; DIAGNOSTIC IMAGING; LIGHT SCATTERING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW;

EID: 0242487827     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conb.2003.09.009     Document Type: Review

References (32)

1. Mansson S, Bjornerud A: Physical principles of medical imaging by nuclear magnetic resonance. In The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. Edited by Merbach AE, Toth I. New York: John Wiley and Sons; 2001: 1-44.
2. Thunus L., Lejeune R. Overview of transition metals and lanthanide complexes as diagnostic tools. Coord. Chem. Rev. 184:1999;125-155.
3. Aime S., Botta M., Fasano M., Terreno E. Prototropic and water-exchange processes in aqueous solutions of Gd(III) chelates. Acc. Chem. Res. 32:1999;941-949.
4. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99:1999;2293-2352.
5. Aime S., Fasano M., Terreno E. Lanthanide(III) chelates for NMR biomedical applications. Chem. Soc. Rev. 27:1998;19-29.
6. Louie AY, Duimstra JA, Meade TJ: Brain Mapping, The Methods edn 2. Edited by Toga WA, Mazziotta CJ. San Diego: Elsevier Science; 2002.
7. Reichert D.E., Lewis J.S., Anderson C.J. Metal complexes as diagnostic tools. Coord. Chem. Rev. 184:1999;3-66.
8. Toth E, Helm L, Merbach AE: Relaxivity of gadolinium(III) complexes: theory and mechanism. In The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. Edited by Toth E, Merbach AE. New York: John Wiley and Sons; 2001:45-120.
9. Bertini IL: NMR of Paramagnetic Molecules in Biological Systems. Edited by Gray HBL. Menlo Park, CA: Benjamin/Cummings; 1986.
10. Banci L, Bertini I, Luchinat C: Nuclear and Electronic Relaxation: The Magnetic Nucleus-Unpaired Electron Coupling in Solution. Edited by Weinheim. New York; 1991.
11. Jacques V., Desreux J.F. New classes of MRI contrast agents. Top Curr. Chem. 221:2002;123-164.
12. Louie A.Y., Huber M.M., Ahrens E.T., Rothbacher U., Moats R., Jacobs R.E., Fraser S.E., Meade T.J. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18:2000;321-325 This paper describes the in vivo imaging of the β-galactosidase marker gene through the use of MRI, presenting the potential of MRI to track gene expression. Upon cleavage of a 'blocking' galactopyranose sugar residue by β-galactosidase, the relaxivity of the agent is enhanced, allowing water access to the inner coordination sphere of the agent.
13. Jacobs R.E., Ahrens E.T., Meade T.J., Fraser S.E. Looking deeper into vertebrate development. Trends Cell Biol. 9:1999;73-76.
14. Li W.-h., Parigi G., Fragai M., Luchinat C., Meade T.J. Mechanistic studies of a calcium-dependent MRI contrast agent. Inorg. Chem. 41:2002;4018-4024.
15. Li W.-h., Fraser S.E., Meade T.J. A calcium-sensitive magnetic resonance imaging contrast agent. Journal of the American Chemical Society. 121:1999;1413-1414.
16. Hanaoka K., Kikuchi K., Urano Y., Nagano T. Selective sensing of zinc ions with a novel magnetic resonance imaging contrast agent. J. Chem. Soc. [Perkin 1]. 2:2001;1840-1843.
17. Zhang S., Wu K., Sherry A.D. A novel pH-sensitive MRI contrast agent. Angew. Chem. Int. Ed. Engl. 38:1999;3192-3194.
18. Mikawa M., Miwa N., Brautigam M., Akaike T., Maruyama A. A pH-sensitive contrast agent for functional magnetic resonance imaging (MRI). Chemistry Letters. 7:1998;693-694.
19. Aime S., Castelli D.D., Terreno E. Novel pH-reporter MRI contrast agents. Angew. Chem. Int. Ed. Engl. 41:2002;4334-4336 An interesting paper presenting a possible solution to overcome the concentration dependence on the signal intensity by using paramagnetic CEST agents.
20. Lowe M.P., Parker D., Reany O., Aime S., Botta M., Castellano G., Gianolio E., Pagliarin R. pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. J. Am. Chem. Soc. 123:2001;7601-7609.
21. Thulborn K.R., Waterton J.C., Matthews P.M., Radda G.K. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim. Biophys. Acta. 714:1982;265-270.
22. Ogawa S., Tank D.W., Menon R., Ellermann J.M., Kim S.G., Merkle H., Ugurbil K. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc. Natl. Acad. Sci. U.S.A. 89:1992;5951-5955.
23. Burai L., Scopelliti R., Toth E. EuII-cryptate with optimal water exchange and electronic relaxation: a synthon for potential pO2 responsive macromolecular MRI contrast agents. Chemical Communications (Cambridge, United Kingdom). 20:2002;2366-2367.
24. Aime S., Botta M., Gianolio E., Terreno E. A p(O2)-responsive MRI contrast agent based on the redox switch of manganese(II/III)-porphyrin complexes. Angew. Chem. Int. Ed. Engl. 39:2000;747-750.
25. Hines J.V., Ammar G.M., Buss J., Schmalbrock P. Paramagnetic oligonucleotides: contrast agents for magnetic resonance imaging with proton relaxation enhancement effects. Bioconjug. Chem. 10:1999;155-158.
26. 3+ magnetic resonance imaging contrast agents with a prominent receptor-induced magnetization enhancement. Angew. Chem. Int. Ed. Engl. 40:2001;2903-2906.
27. De Leon-Rodriguez L.M., Ortiz A., Weiner A.L., Zhang S., Kovacs Z., Kodadek T., Sherry A.D. Magnetic resonance imaging detects a specific peptide-protein binding event. J. Am. Chem. Soc. 124:2002;3514-3515 The authors present a paper describing the programmable use of MRI to track specific proteins in vivo by altering the peptide sequence attached to the contrast agent. This application takes advantage of the protein lock and key methodology.
28. 2 MR contrast agents as a potential detector of oligonucleotide sequences. The experiment demonstrates hybridization to target oligonucleotide sequences enhancing the spin-spin relaxation of the agent.
29. Aime S., Barge A., Delli Castelli D., Fedeli F., Mortillaro A., Nielsen Flemming U., Terreno E. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn. Reson. Med. 47:2002;639-648.
30. Zhang S., Michaudet L., Burgess S., Sherry A.D. The amide protons of an ytterbium(III) dota tetraamide complex act as efficient antennae for transfer of magnetization to bulk water. Angew. Chem. Int. Ed. Engl. 41:2002;1919-1921.
31. Zhang S., Winter P., Wu K., Sherry A.D. A novel Europium(III)-based MRI contrast agent. J. Am. Chem. Soc. 123:2001;1517-1518.
32. Aime S., Delli Castelli D., Fedeli F., Terreno E. A paramagnetic MRI-CEST agent responsive to lactate concentration. J. Am. Chem. Soc. 124:2002;9364-9365.